Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Condition:   Venous Thromboembolism Intervention:   Drug: Apixaban 2.5 MG Sponsors:   Instituto de Investigacion Sanitaria La Fe;   Bristol-Myers Squibb Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials